Hypertension and the J-curve phenomenon: Implications for tight blood pressure control

Hypertension Research

Volumn 36, Issue 2, 2013, Pages 109-111

  Angeli, Fabio ^a   Reboldi, Gianpaolo ^b   Verdecchia, Paolo ^c  

^a Hospital Media Valle Del Tevere   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Hospital of Assisi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY HEMODYNAMICS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; INCIDENCE; J CURVE PHENOMENON; NOTE; ORTHOSTATIC HYPOTENSION; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; HYPERTENSION; MALE; PRODUCT SURVEILLANCE, POSTMARKETING; TETRAZOLES; VALINE;

EID: 84873559360     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.165     Document Type: Note

References (10)

1. Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979; 1: 861-865.
2. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987; 1: 581-584.
3. Verdecchia P, Angeli F, Cavallini C, Mazzotta G, Garofoli M, Martire P, Reboldi G. The optimal blood pressure target for patients with coronary artery disease. Curr Cardiol Rep 2010; 12: 302-306.
4. Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002; 39: 105-110.
5. Psaty BM, Furberg CD, Kuller LH, Cushman M, Savage PJ, Levine D, O'Leary DH, Bryan RN, Anderson M, Lumley T. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med 2001; 161: 1183-1192.
6. Yamazaki T, Kohro T, Chujo M, Ishigaki M, Hashimoto T. The occurrence rate of cerebrovascular and cardiac events in patients receiving antihypertensive therapy from the post-marketing surveillance data for valsartan in Japan (J-VALID). Hypertens Res 2013; 36: 140-150.
7. Rose KM, Tyroler HA, Nardo CJ, Arnett DK, Light KC, Rosamond W, Sharrett AR, Szklo M. Orthostatic hypotension and the incidence of coronary heart disease: the atherosclerosis risk in communities study. Am J Hypertens 2000; 13: 571-578.
8. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (jatos). Hypertens Res 2008; 31: 2115-2127.
9. Cushman WC, Evans GW, Byington RP, Goff Jr DC, Grimm Jr RH, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575-1585.
10. Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, Mureddu G, Pede S, Maggioni AP, Lucci D, Reboldi G. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (cardio-sis): an open-label randomised trial. Lancet 2009; 374: 525-533.